Influenza - In-Depth Notes

Importance of Studying Influenza

  • Cyclical Patterns: Influenza infections increase during winter months in the United States.
  • Terminology Confusion: Many illnesses are incorrectly labeled as the flu; only those caused by influenza viruses are true flu cases.
  • Viral Evolution: Studying influenza viruses helps understand how other viruses can evolve to cause serious diseases.

Types of Influenza

  • Seasonal Influenza: Annual occurrences, typically the only strains circulating.
  • New Strains: Occasionally new strains can emerge, potentially leading to pandemics (e.g., the 2009 H1N1 pandemic).
    • Differences: Variant symptoms, age group impacts, and vaccine protocols.

Signs and Symptoms

  • Initial Effects: Influenza primarily affects the upper respiratory tract, but can impact the lower tract in severe cases.
  • Incubation Period: Symptoms develop within 1 to 4 days post-infection.
  • Common Symptoms:
    • Headache
    • Chills
    • Dry cough
    • Body aches
    • Fever
    • Stuffy nose
    • Sore throat
  • Fatigue: Can last for several days to weeks.
  • Vulnerability: Infections can lead to secondary bacterial infections and pneumonia, especially dangerous for healthy individuals.

Causative Agents

  • Influenza Virus Types: Caused by three main viruses: A, B, and C, belonging to the family Orthomyxoviridae.
    • Structure: Spherical particles (80 to 120 nm) with a lipoprotein envelope and glycoprotein spikes.
    • Key Proteins: Hemagglutinin (H) and Neuraminidase (N).
    • H: Attaches to host cell receptors facilitating viral entry.
    • N: Aids in viral release and spreading through respiratory secretions.

Genetic Variability

  • Antigenic Drift: Gradual mutations in glycoproteins leading to decreased immune recognition, necessitating annual vaccinations.
  • Antigenic Shift: Involves the reassortment of RNA strands between different influenza viruses, potentially leading to new pandemic strains.
    • Example: H1N1 pandemic involved a quadruple reassortment virus from swine, avian, and human sources.

Transmission and Epidemiology

  • Routes of Transmission:
    • Primarily through inhalation of aerosols and droplets.
    • Contact with contaminated surfaces (fomites).
  • Factors Influencing Spread:
    • Crowding and poor ventilation, especially in colder months.
    • Dry air conditions that facilitate viral transmission.
  • Population Impact: Highly contagious; severe impacts on the very young and elderly populations.

Pathogenesis and Virulence Factors

  • Binding: Influenza viruses predominantly attach to ciliated respiratory cells.
  • Immune Response: Overreaction can lead to a cytokine storm and increase lung inflammation.
  • Recovery: Symptoms subside as ciliated epithelium regenerates (1-2 weeks).

Prevention and Treatment

  • Vaccines:
    • Various vaccine types (e.g., inactivated, live attenuated).
    • Annual updates based on predictions of circulating strains, necessitated by antigenic drift.
  • Antiviral Treatments:
    • Zanamivir (Relenza) and Oseltamivir (Tamiflu): Effective if taken early.
    • Baloxavir (Xofluza): Newer antiviral option approved in 2018.
  • Environmental Concerns: Seasonal flu yearly fatalities in the U.S. range from 12,000 to 60,000, with global estimates from 250,000 to 500,000 deaths.

Key Notes

  • Public Health Monitoring: Continuous vigilance for potential new strains is essential.
  • Current Measures: Ongoing research for universal vaccines targeting common epitopes among influenza strains.